首页> 美国卫生研究院文献>Oncology Letters >Small bowel metastasis from pancreatic cancer in a long-term survivalpatient with synchronous advanced malignant pleural mesothelioma: A case report andliterature review
【2h】

Small bowel metastasis from pancreatic cancer in a long-term survivalpatient with synchronous advanced malignant pleural mesothelioma: A case report andliterature review

机译:胰腺癌的小肠转移可长期生存同步性晚期恶性胸膜间皮瘤患者1例文献评论

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Diffuse malignant pleural mesothelioma (MPM) is an aggressive tumor that originates from the surface of the pleura. Approximately 70% of cases are associated with chronic asbestos exposure. MPM is regarded as an incurable disease, with a median survival of ~2 years following intensive multimodality treatment. Pancreatic cancer is a malignancy also associated with a poor prognosis, with only 2% of patients surviving for 5 years. The majority of patients with pancreatic cancer are diagnosed with an advanced stage of disease and experience a poor response to therapy. The development of synchronous MPM and other types of cancer is rare. The present study describes a patient with synchronous, biphasic MPM and pancreatic adenocarcinoma, who was treated with a multimodal therapeutic approach with stereotactic body radiation therapy. Due to a suspected diagnosis of ‘acute abdomen’, an emergency small intestine resection was performed and a subsequent diagnosis of moderately-differentiated adenocarcinoma was confirmed. During a further immunohistochemical examination, pathologists determined that the small bowel metastasis descended from pancreatic cancer. The onset of bowel metastasis is an event rarely associated with MPM, and has not been previously described in the literature for cases of pancreatic cancer. Therefore, to the best ofour knowledge, the present study describes the first case of intestinal metastasisfrom pancreatic cancer in a long-term survival patient with biphasic MPM.
机译:弥漫性恶性胸膜间皮瘤(MPM)是一种侵袭性肿瘤,起源于胸膜表面。大约70%的病例与慢性石棉接触有关。 MPM被认为是不治之症,经过强化多模式治疗后中位生存期约为2年。胰腺癌是一种恶性肿瘤,也与预后不良有关,只有2%的患者存活5年。大多数胰腺癌患者被诊断为疾病晚期,对治疗的反应较差。同步MPM和其他类型癌症的发生是罕见的。本研究描述了患有同步性,双相性MPM和胰腺腺癌的患者,该患者接受了采用立体定向放射疗法的多模式治疗方法的治疗。由于怀疑诊断为“急性腹部”,因此进行了紧急小肠切除术,并随后确认了中度分化腺癌的诊断。在进一步的免疫组织化学检查中,病理学家确定小肠转移源于胰腺癌。肠转移的发生是很少与MPM相关的事件,并且以前在胰腺癌的文献中没有描述过。因此,尽力而为据我们所知,本研究描述了第一例肠转移患有双相MPM的长期生存患者的胰腺癌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号